In vitro selection of Staphylococcus aureus mutants resistant to tigecycline with intermediate susceptibility to vancomycin
- PMID: 26956508
- PMCID: PMC4782574
- DOI: 10.1186/s12941-016-0131-7
In vitro selection of Staphylococcus aureus mutants resistant to tigecycline with intermediate susceptibility to vancomycin
Abstract
Background: Tigecycline (TIG) is an antibiotic belonging to the glycylcyclines class and appears to be a good choice to fight infections caused by Staphylococcus aureus. To date, TIG exhibits good activity against this microorganism. The aim of this work was to obtain in vitro mutants of S. aureus resistant to TIG and evaluate possible changes in their susceptibility patterns to other antibiotics.
Results: Two mutants of S. aureus resistant to TIG (MIC = 16 µg/mL) were selected in vitro from clinical isolates of methicillin-resistant S. aureus. In both mutants, corresponding to different lineage (ST5 and ST239), an increase of efflux activity against TIG was detected. One mutant also showed a reduced susceptibility to vancomycin, corresponding to the VISA phenotype (MIC = 4 µg/mL), with a loss of functionality of the agr locus. The emergence of the VISA phenotype was accompanied by an increase in oxacillin and cefoxitin MICs.
Conclusions: This study demonstrates that, under selective pressure, the increase of efflux activity in S. aureus is one of the mechanisms that may be involved in the emergence of tigecycline resistance. The emergence of this phenotype may eventually be associated to changes in susceptibility to other antibiotics such oxacillin and vancomycin.
Figures


Similar articles
-
Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.BMC Infect Dis. 2006 Oct 26;6:156. doi: 10.1186/1471-2334-6-156. BMC Infect Dis. 2006. PMID: 17067393 Free PMC article.
-
Insights into the molecular basis of reduced vancomycin susceptibility among three prominent Staphylococcus aureus clonal complexes.Microbiol Spectr. 2024 Aug 6;12(8):e0048624. doi: 10.1128/spectrum.00486-24. Epub 2024 Jun 25. Microbiol Spectr. 2024. PMID: 38916317 Free PMC article.
-
In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.J Microbiol Immunol Infect. 2011 Oct;44(5):346-51. doi: 10.1016/j.jmii.2011.01.037. Epub 2011 Jan 20. J Microbiol Immunol Infect. 2011. PMID: 21524980
-
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).Int J Antimicrob Agents. 2007 Nov;30(5):398-408. doi: 10.1016/j.ijantimicag.2007.07.011. Epub 2007 Sep 20. Int J Antimicrob Agents. 2007. PMID: 17888634 Review.
-
Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.Pharmacotherapy. 2015 Apr;35(4):424-32. doi: 10.1002/phar.1577. Pharmacotherapy. 2015. PMID: 25884530 Review.
Cited by
-
Phenotypic and genetic stepwise changes in Staphylococcus aureus during in vitro adaptive laboratory evolution under the selective pressure of tigecycline.Antimicrob Agents Chemother. 2025 May 7;69(5):e0007225. doi: 10.1128/aac.00072-25. Epub 2025 Mar 26. Antimicrob Agents Chemother. 2025. PMID: 40135899 Free PMC article.
-
Efflux Pump Overexpression Contributes to Tigecycline Heteroresistance in Salmonella enterica serovar Typhimurium.Front Cell Infect Microbiol. 2017 Feb 17;7:37. doi: 10.3389/fcimb.2017.00037. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28261566 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous